Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Immunosuppression
100%
Renal Transplant Recipients
100%
Renal Transplantation
60%
Elderly Patients
40%
End-stage Renal Disease
40%
Allograft Loss
40%
Older Individuals
40%
Vulnerability
20%
Quality of Life Improvement
20%
Physiological Differences
20%
Overall Outcome
20%
Acute Rejection
20%
Renal Transplant
20%
Transplantation
20%
Pharmacokinetics
20%
Multivariate Analysis
20%
Treatment Modalities
20%
Successful Treatment
20%
Increasing Age
20%
Long-term Graft Survival
20%
Transplant Population
20%
Death Loss
20%
Patient Death
20%
Immunosuppressive Strategy
20%
Pharmacodynamic Difference
20%
Immunological Differences
20%
Mortality Improvement
20%
Pharmacokinetic Differences
20%
Maintenance Hemodialysis
20%
Elderly Individuals
20%
Transplant Recipients
20%
Pharmacokinetic/pharmacodynamic (PK/PD)
20%
Mortality Benefit
20%
Immunomodulatory Drugs (IMiDs)
20%
Immunosuppressive Medications
20%
Nursing and Health Professions
Immunosuppressive Treatment
100%
Kidney Graft
100%
Immunosuppressive Agent
50%
Kidney Transplantation
50%
End Stage Renal Disease
33%
Elderly Patient
33%
Allograft
33%
Infection
16%
Graft Survival
16%
Acute Graft Rejection
16%
Pharmacodynamics
16%
Quality of Life
16%
Multivariate Analysis
16%
Elderly Individual
16%
Pharmacology, Toxicology and Pharmaceutical Science
Immunosuppressive Agent
100%
End Stage Renal Disease
66%
Pharmacokinetics
66%
Infection
33%
Pharmacodynamics
33%
Acute Graft Rejection
33%